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Nodular Excision of Prostatic Carcinoma 
Experience w i t h Four Patients 
E. E. Steinhardt, M.D.* and A. W. Bohne, M.D.* 
It is well-known that carcinoma of 
the prostate grows slowly for many 
years, remaining relatively innocuous 
for a long period. Predicting the lethal 
potential of the cancerous prostatic 
nodule is therefore uncertain. 
In certain situations, because of this 
slow growth, it may be possible to con-
sider a somewhat less radical treat-
ment than total removal of the gland. 
The four cases reported here illustrate 
these special circumstances—and the 
technique used. 
Our procedure of nodular excision 
may be appropriate under the following 
conditions: 
1. When the radical operative pro-
cedure is not technically feasible for 
one reason or the other. 
2. When the pathological diagnosis 
on the frozen section is equivocal. 
3. When the age and desires of the 
patient makes the preservation of po-
tency and continence highly desirable. 
Background—Prognosis 
Gleason's classification^ of the mi-
croscopic cell pattern in prostatic car-
cinoma gives us as accurate a prognosis 
from the microscopic slide as the urol-
ogist can get from the clinical, labora-
tory and x-ray findings. After classify-
ing the degree of differentiation of 
prostatic carcinoma into five patterns, 
he combined these patterns with tumor 
staging and developed a much im-
proved index for prognosis. 
On the other hand, Jewett et al-
have been unable to demonstrate the 
potential biological activity of a can-
cerous prostatic nodule by any routine 
histologic technique. Some nodules of 
low grade cancer grow rapidly and 
metastasize early; others are dormant 
for years. In Jewett's series of 86 pa-
tients with locally limited prostatic 
cancer, one third lived 15 years free 
of the disease after undergoing radical 
perineal prostatectomy. This was twice 
the cure rate of those given endocrine 
treatment. 
The well-documented reports of the 
Veterans Administration Cooperative 
Urological Research Group''-** showed 
that the median survival time for the 
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3,100 patients studied was 31/2 years. 
The most important factor in deter-
mining the prognosis in these patients 
was the high mortality rate from un-
related diseases; 67% of the deaths 
were from intercurrent diseases. 
Barnes' showed that "the 15-year 
survival of patients with early prostatic 
carcinoma, who were treated conser-
vatively, is almost the same as it is in 
similar cases treated by total prosta-
tectomy". The average age of his pa-
tients was 66 years. 
As Watson**' and other investiga-
tors'"- " have reported, the prognosis is 
better in older patients, for whom pros-
tatic cancer seems less lethal. 
A finding of perineural invasion 
seems to have little influence on the 
outcome. Roden et aP- demonstrated 
that the so-cafled perineural lymphatics 
have no endothelial lining, and that 
no lymphatics could be seen in the 
perineurium with the electron micro-
scope. They concluded that cancer 
spreads along the nerves in the prostate, 
within the tissue planes of least resist-
ance, and not in lymphatics. 
In the Veterans Research Group, 
patients who were given estrogens fol-
lowing radical prostatectomy for Stage 
I and Stage I I carcinoma had a lower 
survival rate than those who were given 
postoperative placebos. Estrogen ther-
apy increased the risk of death from 
cardiac and cerebrovascular causes. 
Four Case Histories 
Four patients between the ages of 50 and 
70 years were presented for evaluation and 
treatment of solitary prostatic nodule. All 
were essentially asymptomatic, and pre-
operative studies showed no clinical, bio-
chemical or radiological evidence of exten-
sion. They were all classified as Stage I 
with nodules measuring 0.5 cm, 0.7 cm, 1 
cm, and 1.1 cm, respectively. 
After open perineal biopsy, the nodule 
was electrosurgically excised widely. Sur-
rounding tissue was excised and submitted 
separately for microscopic examination. The 
base was then fulgurated. 
In one 61-year-old patient, the pathologist 
reported a well differentiated small gland 
type of adenocarcinoma surrounded by nor-
mal tissue. In another 61-yearold man, the 
report showed focal nodular areas of adeno-
carcinoma with perineural lymphatic in-
vasion. In this patient, sections from sur-
rounding prostatic tissue were normal. 
Frozen sections from the third patient, 55 
years old, were indeterminate. The perman-
ent sections later showed round atypical cells 
with perineural invasion extending to the 
resected edge of the specimen. 
In the fourth patient, 56 years old, the 
frozen sections showed no evidence of car-
cinoma. Permanent sections showed adeno-
carcinomas without perineural invasion. 
Our patients averaged 12 days' stay 
postoperatively, with an uneventful 
postoperative course except for a mild 
urinary tract infection in one patient. 
All patients were continent and potent. 
These four patients have been followed 
for periods up to nine years and are 
asymptomatic with no treatment other 
than that described. They did not re-
ceive hormones or irradiation therapy, 
nor was an orchiectomy performed. 
Current physical examinations on afl 
four show a benign smooth gland. 
Laboratory studies are normal. 
We do not suggest that nodular exci-
sion of prostatic carcinoma as practiced 
by us is an equivalent substitute for 
radical prostatectomy. The best method 
for a possible cure still seems to be 
total surgical removal of the prostate, 
as originally practiced by Young, later 
modified by Hudson and Belt, and the 
procedure developed by Miflin and 
others.-' '--'^ The authors' experience 
with radical prostatectomy in other 
patients is similar to theirs. 
Summary 
Four patients, 50 to 70 years of 
age, each with a solitary prostatic nod-
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ule but otherwise asymptomatic, were 
referred for evaluation and treatment. 
Preoperative studies showed no clinical, 
biochemical or radiological evidence of 
extension. They were classified as be-
longing in Stage I . All underwent open 
perineal biopsy. At surgery, for one 
reason or another, a radical prostatec-
tomy was not done. In some, frozen 
tissue diagnosis was equivocal and per-
manent sections later showed definite 
adenocarcinoma. When radical pro-
cedure was not indicated, or could not 
be completed, the nodule was electro-
surgically excised and the base fulgur-
ated. After nine years of followup, 
these patients show no evidence of 
recurrence and are asymptomatic. 
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